dual CK2/PIM kinase inhibitors (AstraZeneca)

N/A

Report date: 2025/03/19 09:01:40
NME

Base Information

Drug Namedual CK2/PIM kinase inhibitors (AstraZeneca)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase pim inhibitorsCasein kinase II inhibitors
TargetsSerine/threonine-protein kinase pimCasein kinase II
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Pharmaceuticals Lp
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceuticals Lp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A